1290049-37-4Relevant articles and documents
DIAZEPAM DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTORS
-
Page/Page column 111-112, (2011/05/06)
The invention is concerned with novel bicyclic compounds of Formula (I), wherein n, m, p, A, L, R1, R2, R3, R4, R5, R6, R7, R7, R8, R9 and R10 are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds are antagonists of CCR2 receptor, CCR5 receptor and/or CCR3 receptor and can be used as medicaments.